Help
Subscribe


Submit Videos to GastroHep Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Polypectomy rate as a surrogate for adenoma detection rate

Polypectomy rate as a surrogate for adenoma detection rate varies by colon segment, gender, and endoscopist, reports the latest issue of the Clinical Gastroenterology & Hepatology.

News image

The adenoma detection rate is an important measure of the quality of colonoscopy.

It is associated with interval colorectal cancer and varies among sexes and locations.

Recommended indicators of competence for colonoscopy include minimal adenoma detection rate >25% for average-risk men and >15% for women.

These adenoma detection rates are rigorous, so polypectomy detection rate has been suggested as a surrogate.

Colonoscopy is less effective in the proximal colon, where interval cancers are more likely to occur.

Dr Madhusudhan Sanaka and colleagues compared adenoma detection rates and polypectomy detection rates in different segments of colon and between sexes.

The mean overall polypectomy detection rate was 42%
Clinical Gastroenterology & Hepatology

The research team performed a cross-sectional review of findings from 2167 screening colonoscopies performed by 65 endoscopists on average-risk outpatients at the Cleveland Clinic, 20082009.

The team reviewed colonoscopy and pathology reports of randomly selected procedures.

The researchers calculated polypectomy detection rates, adenoma detection rates, and correlation between polypectomy and adenoma detection rate for each colon segment and sex.

The team found that the mean overall polypectomy detection rate was 42%, and adenoma detection rate was 25%.

The team noted that the correlation between overall adenoma detection rate and polypectomy detection rate was stron.

Polypectomy detection rate of 40% in men and 30% in women correlated with the established minimum benchmark adenoma detection rates of 25% and 15% for men and women, respectively.

Polypectomy detection rate was more strongly correlated with adenoma detection rate in the proximal colon than the distal colon.

The researcher's correlation was stronger in men than in women, as well as in the entire colon, the proximal colon, and the distal colon.

The advanced adenoma detection rate was 4% and did not correlate with polypectomy detection rate.

Dr Sanaka's team concludes, "On the basis of a review of findings from screening colonoscopies, overall polypectomy detection rate correlates with adenoma detection rate for the entire colon, but polypectomy detection rate and adenoma detection rate correlate most strongly for the proximal colon, where many adenomas can be missed and interval cancers develop."

"The correlation between polypectomy detection rate and adenoma detection rate is weaker for women than men and for distal colon."

"If polypectomy detection rate is used as a surrogate for adenoma detection rate, colon location and patient sex should be considered."

Clin Gastroenterol Hepatol 2014: 12(7): 11371142
30 June 2014

Go to top of page Email this page Email this page to a colleague

 28 August 2015

Advanced search
 28 August 2015 
Statin use and survival in pancreatic cancer
 28 August 2015 
Bacterial endotoxin and NAFLD
 28 August 2015 
Interferon-free regimens for Hep C
 27 August 2015 
HCV in Egypt
 27 August 2015 
Gene expression for hepatocellular carcinoma
 27 August 2015 
Liver abnormalities in celiac disease
 26 August 2015 
Medical management of diverticular disease
 26 August 2015 
Treatment of erosive esophagitis
 26 August 2015 
Dermatological complications of anti-TNF therapy in IBD
 25 August 2015 
Markers for colorectal cancer screening
 25 August 2015 
Long-term PPI use and serum gastrin levels
 25 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Treatment for HCV and HIV-1 co-infection
 24 August 2015 
Cirrhosis in Hepatitis C patients
 24 August 2015 
Aspirin use and colorectal cancer survival
 21 August 2015 
Activity indexes in ulcerative colitis
 21 August 2015 
Coffee and gallstone disease
 21 August 2015 
Alcoholic cirrhosis in relapse after liver transplant
 20 August 2015 
Cirrhosis in the USA
 20 August 2015 
Mortality causes in liver cirrhosis
 20 August 2015 
Risk of death in IBD
 19 August 2015 
Predicting intestinal surgery in Crohn's disease
 19 August 2015 
Improved screening colonoscopy quality
 19 August 2015 
Sleep positioning device reduces reflux
 18 August 2015 
Health insurance influences HCV screening outcomes
 18 August 2015 
Somatostatin analogues in polycystic liver disease
 18 August 2015 
Global consensus report on H. pylori gastritis
 17 August 2015 
Biomarker of fibrosis stage in NAFLD
 17 August 2015 
Prognostic score for primary biliary cirrhosis
 17 August 2015 
Measuring subjective health in patients with IBS
 14 August 2015 
Factors that influence ulcerative colitis procedure type
 14 August 2015 
H. pylori in African American and Hispanic veterans
 14 August 2015 
Hep E virus in decompensated chronic liver disease
 13 August 2015 
H. pylori in drinking water
 13 August 2015 
Sofosbuvir-regimens in HCV
 13 August 2015 
IBS among Japanese adolescents
 12 August 2015 
Infliximab in patients in IBD
 12 August 2015 
Peritoneal carcinomatosis in colorectal cancer
 12 August 2015 
Predictors of severity of IBD
 11 August 2015 
H. pylori and immune thrombocytopenic purpura
 11 August 2015 
Chemotherapy and intestinal microbiomes
 11 August 2015 
Sexual dysfunction after rectal cancer treatment
 10 August 2015 
Scoring systems to predict alcoholic hepatitis outcomes
 10 August 2015 
Sofosbuvir-based regimens in veterans with HCV
 10 August 2015 
Predicting lymph node metastasis in T1 colorectal cancer
 07 August 2015 
Factors associated with changes in ulcerative colitis
 07 August 2015 
Bariatric surgery and NASH in obese patients
 07 August 2015 
Caffeine and fibrosis in Hep C
 06 August 2015 
Disparities in colonoscopic examination
 06 August 2015 
Weight loss and NASH
 06 August 2015 
Diagnosis of IBS
 05 August 2015 
Gender differences in fecal immunochemical tests
 05 August 2015 
Adenoma detection rates with a screening colonoscopy program
 05 August 2015 
Extraintestinal manifestations in IBD diagnosis
 04 August 2015 
IBD environmental risk factors
 04 August 2015 
Measuring disease activity in Crohn's
 04 August 2015 
Gastric emptying and hyperglycemia in diabetes
 03 August 2015 
Vaccinations and IBD
 03 August 2015 
Lack of response to therapy in severe ulcerative colitis
 03 August 2015 
Nutritional vs biological therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us